Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NamePeijia-B
Stock Code09996
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們專注於中國高增長的介入手術醫療器械市場,且為中國各經導管瓣膜治療醫療器械市場及神經介入手術醫療器械市場中具領先地位的國內參與者。
Listing Date2020-05-15
Listing Rules EraOld Rules
Listing Rules Chapter18A生物科技
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國江蘇省蘇州市蘇州工業園區中田巷8號
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitewww.peijiamedical.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 15.36 / shares
Offer Price RangeFinal offer price only, no range
Lot Size1,000 shares
Entry ThresholdHK$ 15,360
Par ValueTo be extracted
Offer Period2020-05-05 to 2020-05-08
Global Offering Shares152,511,000 shares
HK Public Offer Shares (Initial)15,252,000 shares (10.0%)
Public Offer Lots (Initial)15,252lots (Pool A7,626lots,Pool B7,626lots)
International Placing Shares (Initial)137,259,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO610,044,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share50.0%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 2,342,568,960

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 1,000 HK$ 15,360
2 lots 2,000 HK$ 30,720
3 lots 3,000 HK$ 46,080
4 lots 4,000 HK$ 61,440
5 lots 5,000 HK$ 76,800
6 lots 6,000 HK$ 92,160
7 lots 7,000 HK$ 107,520
8 lots 8,000 HK$ 122,880
9 lots 9,000 HK$ 138,240
10 lots 10,000 HK$ 153,600
15 lots 15,000 HK$ 230,400
20 lots 20,000 HK$ 307,200
25 lots 25,000 HK$ 384,000
30 lots 30,000 HK$ 460,800
35 lots 35,000 HK$ 537,600
40 lots 40,000 HK$ 614,400
45 lots 45,000 HK$ 691,200
50 lots 50,000 HK$ 768,000
60 lots 60,000 HK$ 921,600
70 lots 70,000 HK$ 1,075,200
80 lots 80,000 HK$ 1,228,800
90 lots 90,000 HK$ 1,382,400
100 lots 100,000 HK$ 1,536,000
200 lots 200,000 HK$ 3,072,000
300 lots 300,000 HK$ 4,608,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
400 lots 400,000 HK$ 6,144,000
500 lots 500,000 HK$ 7,680,000
600 lots 600,000 HK$ 9,216,000
700 lots 700,000 HK$ 10,752,000
800 lots 800,000 HK$ 12,288,000
900 lots 900,000 HK$ 13,824,000
1,000 lots 1,000,000 HK$ 15,360,000
1,500 lots 1,500,000 HK$ 23,040,000
2,000 lots 2,000,000 HK$ 30,720,000
2,500 lots 2,500,000 HK$ 38,400,000
3,000 lots 3,000,000 HK$ 46,080,000
3,500 lots 3,500,000 HK$ 53,760,000
4,000 lots 4,000,000 HK$ 61,440,000
4,500 lots 4,500,000 HK$ 69,120,000
5,000 lots 5,000,000 HK$ 76,800,000
6,000 lots 6,000,000 HK$ 92,160,000
7,000 lots 7,000,000 HK$ 107,520,000
7,626 lots 7,626,000 HK$ 117,135,360

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 3.38B
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +187%

Valuation & Financials

Market Cap (at Offer Price)HK$ 9,370,275,840
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 142,268,960
Listing Expenses / Funds Raised~6.07%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Balance Sheet
Item 2018
Cash and cash equivalents 28,782
Inventories 5,506
Total current assets 82,420
Total assets 136,167
Total current liabilities 44,287
Total liabilities 47,530
Total equity 88,637
Equity attributable to owners 89,573
Cash Flow Statement
Item 2018
Net cash from operating activities -25,089
Net cash from investing activities -1,361
Net cash from financing activities 53,558
Net increase in cash 27,108
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 25.8
First Day OpenHK$ 26.8
First Day Change67.97%
First Day Volume93141300.0
First Day Turnover2441970000.0
Use of Proceeds
1、約65.0%(或1,430.2百萬港元),將撥作開發及商業化我們的核心產品TaurusOne?以及其他主要在研產品; 2、約10.0%(或220.0百萬港元),將用于我們管線中的其他在研產品的正在進行的臨床前研究及擬訂的臨床試驗、準備注冊備案及潛在商業化推出; 3、約8.0%(或176.0百萬港元),將用于加強我們的研發能力以豐富我們的產品管線,其主要包括為我們的內部研發團隊招聘及支付三年薪金予高素質人才,尤其是具有豐富設計及開發技能及經驗的工程師; 4、約10.0%(或220.0百萬港元),將用于通過潛在戰略收購、投資、合作伙伴及許可機會以擴大我們的產品組合或知識產權組合; 5、約7.0%(或154.1百萬港元),將用作營運資金及其他一般企業用途。

Underwriting Syndicate

Joint Sponsors (2)
Morgan Stanley Asia Limited CE AAD291 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809
Overall Coordinators (4)
Morgan Stanley Asia Limited CE AAD291 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 BOCI ASIA LIMITED CE AET863 UBS Securities Hong Kong Limited CE BIN466
Joint Bookrunners (6)
Morgan Stanley Asia Limited CE AAD291 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 BOCI ASIA LIMITED CE AET863 UBS Securities Hong Kong Limited CE BIN466 招银国际融资有限公司 CE AVM940 国泰君安证券(香港)有限公司 CE ABY236
Joint Lead Managers (6)
Morgan Stanley Asia Limited CE AAD291 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 BOCI ASIA LIMITED CE AET863 UBS Securities Hong Kong Limited CE BIN466 招银国际融资有限公司 CE AVM940 国泰君安证券(香港)有限公司 CE ABY236

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 AIHC Master Fund 7,741,440 HKD — 0.33% — 6 months 2020-11-15
2 Cormorant Asset Management, LP 62,008,320 HKD — 2.65% — 6 months 2020-11-15
3 Fidelity International 387,548,160 HKD — 16.54% — 6 months 2020-11-15
4 Hudson Bay Master Fund LTD 77,506,560 HKD — 3.31% — 6 months 2020-11-15
5 LAV Aero Limited 38,753,280 HKD — 1.65% — 6 months 2020-11-15
6 Octagon Investments Master Fund LP 62,008,320 HKD — 2.65% — 6 months 2020-11-15
7 OrbiMed Funds 77,506,560 HKD — 3.31% — 6 months 2020-11-15
8 Prime Capital Funds 100,761,600 HKD — 4.30% — 6 months 2020-11-15
9 Rock Springs Capital Master Fund LP 62,008,320 HKD — 2.65% — 6 months 2020-11-15
10 Sage Partners Master Fund 7,741,440 HKD — 0.33% — 6 months 2020-11-15
11 常春藤资产管理(香港)有限公司 7,741,440 HKD — 0.33% — 6 months 2020-11-15
12 铭基基金 77,506,560 HKD — 3.31% — 6 months 2020-11-15
13 新华资本管理有限公司 46,494,720 HKD — 1.98% — 6 months 2020-11-15
14 中国国有企业结构调整基金股份有限公司 155,013,120 HKD — 6.62% — 6 months 2020-11-15

Directors & Management

PositionChinese nameEnglish Name
Chairman張一—
Company Secretary周慶齡—
No director data available.

Major Shareholders

Major Shareholders & Holdings張一(張博士)、張葉萍太太、葉紅女士、Jinnius Drive Trust、Hanlindale Trust及XinYue International Limited為一致行動人士,緊隨全球發售完成後合共持有約23.68%投票權;LAV合共持有約10.23%;HH SUM-XXIV Holdings Limited持有約6.84%;Matrix Partners China IV, L.P.及Matrix Partners China IV-A, L.P.合共持有約6.50%;祝進女士持有約5.91%。
About this page

This page shows Peijia-B (09996) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect